Literature DB >> 11730923

Interest in preeclampsia for researchers in reproduction.

Pierre Yves Robillard1.   

Abstract

Gestational hypertension/preeclampsia, is a major disease of human reproduction, with 10% of human births being affected. It is due to the failure of extravillous cytotrophoblast to invade the maternal uterine spiral arteries to a sufficient depth at the second physiological invasion around the 14-16th week of gestation, inducing poor vascular exchanges between the mother and the placenta. The rise of blood pressure in the human mother is then a compensatory mechanism to increase the exchanges and try to save the fetus from poor supplies. Indeed, it is only in the late 1970s that a puzzling phenomenon has been described: in human pregnancy, in contrast with other mammals, implantation of the embryo occurs by two physiological invasions of the cytotrophoblast inside the uterine wall: (a) at the beginning of pregnancy after fecundation (like all mammals); (b) then follows an apparent long pause (6-8 weeks) and (c) late at the end of first trimester (14-16th week) of gestation, a second very deep (1/3 of the uterine wall) invasion. This two-wave physiological endovascular trophoblast invasion represents a remarkable immunological placental-maternal interaction. Moreover, preeclampsia which has been considered as 'the disease of primigravidae' during all the XXth century may be in fact associated with new paternity especially in couples conceiving very shortly after the beginning of their sexual relationship. 'Primipaternity', rather than primigravidity, is probably the leading cause of preeclampsia. Comprehension in the near future of the physiological immunological tolerance in normal pregnancies and immunological rejection (preeclampsia) of the second trophoblastic invasion will give the biological clue of this puzzling disease, real plague of human reproduction.

Entities:  

Mesh:

Year:  2002        PMID: 11730923     DOI: 10.1016/s0165-0378(01)00081-x

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  5 in total

1.  Potential biomarkers and molecular mechanisms in preeclampsia progression.

Authors:  Guohua Li; Shijia Huang; Xiaosong Liu; Qiaoling Du
Journal:  Open Life Sci       Date:  2022-05-18       Impact factor: 1.311

2.  Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia.

Authors:  Ilknur Kaleli; Babur Kaleli; Melek Demir; Basak Yildirim; Nural Cevahir; Suleyman Demir
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 3.  HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia.

Authors:  Snezana Djurisic; Thomas Vauvert F Hviid
Journal:  Front Immunol       Date:  2014-12-23       Impact factor: 7.561

4.  Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion.

Authors:  Elsebeth Staun-Ram; Shlomit Goldman; Eliezer Shalev
Journal:  Reprod Biol Endocrinol       Date:  2009-11-25       Impact factor: 5.211

5.  Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells.

Authors:  Anne Schumacher; Paul Ojiambo Wafula; Ana Teles; Tarek El-Mousleh; Nadja Linzke; Maria Laura Zenclussen; Stefanie Langwisch; Kristina Heinze; Ivonne Wollenberg; Pablo Ariel Casalis; Hans-Dieter Volk; Stefan Fest; Ana Claudia Zenclussen
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.